Skip to main content
. 2003 Feb;185(3):870–878. doi: 10.1128/JB.185.3.870-878.2003

TABLE 2.

Plasmids used in this study

Plasmid Relevant featuresa Source or reference(s)
pBR322 Apr Tcr; cloning vector 5
pUC19 Apr; cloning vector 59
pUC18Ery Apr Emr; derivative of pUC18 carrying an ery gene 50
pUC19Ery Apr Emr; derivative of pUC19 carrying an ery gene 32
pNZ8020 Cmr; inducible expression vector carrying the nisA promoter 14
pNZ8400 Apr; 2.4-kbp SstI fragment of Lactococcus lactis cloned in pUC19 This studyb
pNZ8401 Apr; pNZ8400 derivative with a ScaI/StuI 380-bp deletion in the galK reading frame This studyb
pNZ8402 Apr Emr; XbaI/PstI fragment of pUC19Ery containing the ery gene and cloned in pNZ8401 This studyb
pNZ8410 Apr; 7.3-kbp SalI/EcoRI fragment of Lactococcus lactis cloned in pBR322 This studyb
pNZ8421 Apr; 1.8-kbp EcoRI fragment of pNZ8410 containing galE cloned in pBR322, orientation 1 This studyb
pNZ8422 Apr; same as pNZ8421, orientation 2 This studyb
pNZ8442 Apr; 2.5-kbp SalI/NheI fragment of pNZ8410 containing galP cloned in pUC18 This studyb
pNZ8451 Apr Emr; 1.1-kbp internal HpaII fragment of galP cloned in pUC18Ery, orientation 1 This studyb
pNZ8452 Apr Emr; same as pNZ8452, orientation 2 This studyb
pNZ8460 Apr Emr; internal 0.8-kbp fragment of galE cloned in pUC18Ery This studyb
pNZ8560 Cmr; 1.8-kbp EcoRI fragment of pNZ8410 containing galE cloned in pNZ8020 This studyb
a

Emr, Apr, Cmr, and Tcr, resistance to erythromycin, ampicillin, chloramphenicol, and tetracycline, respectively.

b

See Materials and Methods and Fig. 1.